Percutaneous SAPIEN S3 Transcatheter Valve Implantation for Post-Left Ventricular Assist Device Aortic Regurgitation

Angela Kornberger; Andres Beiras-Fernandez; Stephan Fichtlscherer; Birgit Assmus; Anton Moritz; Ulrich A Stock

doi:10.1016/j.athoracsur.2015.06.089

Percutaneous SAPIEN S3 Transcatheter Valve Implantation for Post-Left Ventricular Assist Device Aortic Regurgitation

Ann Thorac Surg. 2015 Oct;100(4):e67-9. doi: 10.1016/j.athoracsur.2015.06.089.

Authors

Angela Kornberger¹, Andres Beiras-Fernandez², Stephan Fichtlscherer³, Birgit Assmus³, Anton Moritz², Ulrich A Stock²

Affiliations

¹ Department of Thoracic and Cardiovascular Surgery, University Hospital, Goethe University, Frankfurt, Germany. Electronic address: angela.kornberger@kgu.de.
² Department of Thoracic and Cardiovascular Surgery, University Hospital, Goethe University, Frankfurt, Germany.
³ Department of Cardiology, University Hospital, Goethe University, Frankfurt, Germany.

PMID: 26434481
DOI: 10.1016/j.athoracsur.2015.06.089

Abstract

Aortic regurgitation was found to develop in a considerable share of patients supported with continuous flow left ventricular assist devices (LVADs). The resulting circulatory loop renders LVAD operation inefficient so that symptoms of heart failure develop in spite of high LVAD flows. In patients with a high reoperative risk, transcatheter aortic valve implantation may be considered as an alternative to reoperative valve surgical procedures. We report a case of percutaneous transcatheter aortic valve implantation using the SAPIEN S3 (Edwards Lifesciences, Inc, Irvine, CA) valve for post-LVAD aortic regurgitation.

Publication types

Case Reports

MeSH terms

Aortic Valve Insufficiency / etiology*
Aortic Valve Insufficiency / therapy*
Aortic Valve*
Cardiomyopathy, Dilated / surgery
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Heart-Assist Devices*
Humans
Male
Middle Aged